IB
InSitu Biologics, Inc.
SEC filingBiotechnology · Oakdale, MN
Amount raised$1.3Msold at filing
Total offering$2.5M$1.3M still open
Investors in the raise1count reported to the SEC
FiledAug 10, 2026first sale Aug 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bill TaylorExecutive Officer
Robert WilsonDirector
Greg Van GuilderDirector
Ivan ShawDirector
Daniel HalpernExecutive Officer, Director
Sandi KlemannExecutive Officer
Executive officers, directors and promoters as listed on the Form D.